Grafix

Osiris FDA Letter: Trick or Treat?

Osiris, a cellular therapy biotech, recently received a so-called “untitled letter” from the FDA. The text of the letter seems on the whole negative in my opinion, while the company’s public reaction to the letter on the other hand could be seen paradoxically as rather cheery. What’s going on here? With Halloween coming, one has …

Osiris FDA Letter: Trick or Treat? Read More »

Pete Shuster on His Choice of Best Stem Cell Company: Osiris

Osiris

This is the first in a series of guest posts on what folks believe are the best compliant stem cell companies out there. You can submit a potential guest post on this topic to me until August 30. Editor’s notes: Pete submitted this to me on Sunday, well before today’s big Osiris news. He must …

Pete Shuster on His Choice of Best Stem Cell Company: Osiris Read More »

Osiris success with Diabetic foot ulcers is a giant step

Osiris

Stem cell & cellular medicine biotech, Osiris, reported a major success today with its cell-based treatment of Diabetic foot ulcers. The data are about as good as it gets. The company’s Grafix product for the ulcers was three times more effective than the control. A cross-over phase where those given the control were switched to …

Osiris success with Diabetic foot ulcers is a giant step Read More »